文献速递真菌感染新发突发、热带与寄生虫病

COVID-19相关曲霉病的不确定性:与流感相关曲霉病的比较

Navigating the Uncertainties of COVID-19-Associated Aspergillosis: A Comparison With Influenza-Associated Aspergillosis.
PubMed 文献 · J Infect Dis · 2021-01-01

该文比较了流感相关肺曲霉病(IAPA)与COVID-19相关肺曲霉病(CAPA)的异同。CAPA多数病例被归类为疑似而非确诊/很可能IPA,流感和COVID-19的不同病理生理可能解释这些差异。CAPA是否为独立实体仍有争议,其实际发病率、皮质类固醇或免疫调节药物的易感作用及抗真菌治疗指征等问题尚待解答。

要点

  • CAPA多数为疑似IPA,确诊/很可能IPA较少,与IAPA分类不同。
  • 流感和COVID-19病理生理差异可能解释CAPA与IAPA的分类差异。
  • CAPA实际发病率、激素/免疫调节药物作用及抗真菌治疗指征尚不明确。

核心结论

  • CAPA多数病例被归类为疑似而非确诊/很可能IPA,与IAPA不同,CAPA是否为独立实体仍有争议。

研究设计与样本

  • 本文为叙述性比较文章,讨论流感相关肺曲霉病(IAPA)与COVID-19相关肺曲霉病(CAPA)的异同,未报告系统检索范围或样本量。

主要发现

  • 与IAPA相比,CAPA多数病例被归类为疑似而非确诊/很可能IPA。
  • 流感和COVID-19的不同病理生理可能解释CAPA与IAPA分类的差异。

临床怎么用

  • 临床应认识到CAPA诊断多基于疑似标准,确诊/很可能IPA比例较低,需结合诊断策略和定义解读CAPA发生率。

局限性

  • CAPA实际发病率、皮质类固醇或免疫调节药物的易感作用及抗真菌治疗指征等关键问题尚未解答。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Invasive pulmonary aspergillosis (IPA) is increasingly recognized as a life-threatening superinfection of severe respiratory viral infections, such as influenza. The pandemic of Coronavirus Disease 2019 (COVID-19) due to emerging SARS-CoV-2 rose concern about the eventuality of IPA complicating COVID-19 in intensive care unit patients. A variable incidence of such complication has been reported, which can be partly attributed to differences in diagnostic strategy and IPA definitions, and possibly local environmental/epidemiological factors. In this article, we discuss the similarities and differences between influenza-associated pulmonary aspergillosis (IAPA) and COVID-19-associated pulmonary aspergillosis (CAPA). Compared to IAPA, the majority of CAPA cases have been classified as putative rather than proven/probable IPA. Distinct physiopathology of influenza and COVID-19 may explain these discrepancies. Whether CAPA represents a distinct entity is still debatable and many questions remain unanswered, such as its actual incidence, the predisposing role of corticosteroids or immunomodulatory drugs, and the indications for antifungal therapy.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Lamoth F, Lewis RE, Walsh TJ, et al. Navigating the Uncertainties of COVID-19-Associated Aspergillosis: A Comparison With Influenza-Associated Aspergillosis. J Infect Dis. 2021. PMID: 33770176. doi:10.1093/infdis/jiab163

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。